AKT1 and renal cell adenocarcinoma: Before long, Zhang et al. demonstrated that TREM2 was abnormally upregulated in renal cell cancer tissues, knockdown of TREM2 significantly inhibited the progression of renal cell cancer via inactivating PI3K/Akt signaling pathway and increasing the expression of PTEN (81).